Hydrogenated Ergot Alkaloids
Hydrogenated Ergot Alkaloids Brand names, Hydrogenated Ergot Alkaloids Analogs
- Alkergot
- Circanol
- Co-Dergocrine Mesylate
- Deapril-ST
- Dihydroergotoxin Mesilat
- Dihydroergotoxin Mesylate
- Dihydroergotoxin Methanesulfonate
- Dihydroergotoxine Mesilate
- Dihydroergotoxine Mesylate
- Dihydroergotoxine Methanesulfonate
- Dihydroergotoxine Methanesulphonate
- Ergoloid Mesylates [Usan]
- Gerimal
- Hydergin
- Hydergine
- Hydergine LC
- Hydrogenated Ergot Alkaloids
- Ischelium
- Redergin
- Trigot
Hydrogenated Ergot Alkaloids Brand Names Mixture
- No information avaliable
Hydrogenated Ergot Alkaloids Chemical_Formula
C33H45N5O5
Hydrogenated Ergot Alkaloids RX_link
No information avaliable
Hydrogenated Ergot Alkaloids fda sheet
Hydrogenated Ergot Alkaloids msds (material safety sheet)
Hydrogenated Ergot Alkaloids Synthesis Reference
No information avaliable
Hydrogenated Ergot Alkaloids Molecular Weight
591.741 g/mol
Hydrogenated Ergot Alkaloids Melting Point
No information avaliable
Hydrogenated Ergot Alkaloids H2O Solubility
No information avaliable
Hydrogenated Ergot Alkaloids State
Solid
Hydrogenated Ergot Alkaloids LogP
2.615
Hydrogenated Ergot Alkaloids Dosage Forms
Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet
Hydrogenated Ergot Alkaloids Indication
For use as an adjunct therapy for patients with dementia
Hydrogenated Ergot Alkaloids Pharmacology
Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.
Hydrogenated Ergot Alkaloids Absorption
Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.
Hydrogenated Ergot Alkaloids side effects and Toxicity
Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.
Hydrogenated Ergot Alkaloids Patient Information
No information avaliable
Hydrogenated Ergot Alkaloids Organisms Affected
Humans and other mammals
